Product Description
Rediscover a clear and even complexion with the ACM Dépiwhite Advanced cream, formulated by the renowned Laboratoire Dermatologique ACM in France. This intensive treatment blends French pharmaceutical expertise with cutting-edge skincare science to target stubborn brown spots caused by sun exposure, aging, or pregnancy mask (melasma). By stimulating the biodegradation of melanin, this cream delivers a visible brightening effect on the face, décolleté, and hands.
ACM Dépiwhite Advanced Cream Specifications
The ACM Dépiwhite Advanced is engineered with high-performance ingredients to tackle pigmentation issues:
Intensive Spot Treatment: Specifically targets and fades existing brown spots through a potent blend of depigmenting agents.
Melanin Biodegradation: Accelerates the natural breakdown of excess melanin responsible for dark patches.
Preventative Action: Helps limit the reappearance of spots by regulating melanin production at its source.
Multi-Area Application: Clinically safe for use on the face, neck area (décolleté), and hands.
Lightweight Texture: A fast-absorbing cream that integrates easily into your daily routine without leaving a greasy film.
Made in France: A high-quality dermatological solution developed and manufactured in France to ensure maximum efficacy and safety.
Why Use This Product & Who Is It For?
- This cream is ideal for anyone dealing with melasma, sun spots, or uneven skin tone.
- It is suitable for all skin types seeking an effective, targeted treatment to restore skin clarity and achieve a long-lasting radiant glow.
How to Use
Apply the cream once daily only to the affected areas (the spots) on the face, décolleté, or hands.
Use primarily in the evening; if used during the day, it is essential to follow up with high-protection sunscreen.
For best results, use consistently for a period of 2 to 6 months.
Directions & Cautions
For external use only.
Avoid direct contact with the eyes.
Store in a cool, dry place away from direct sunlight.










There are no reviews yet.